Clinical Trial

A Phase Ib Clinical Study of AC-003 Capsules in Subjects With aGVHD.

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The study was an open-label, single-arm, dose-escalation, Phase Ib, multi-center study to investigate safety, pharmacokinetics, pharmacodynamics and preliminary efficacy of AC-003 in patients with grade II-IV SR-aGVHD.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-08; most recent amendment 2026-03-13.
Trial Details
NCT Number NCT07070674
Lead Sponsor Accro Bioscience (Suzhou) Limited
Conditions Acute Graft-versus-Host Disease
Enrollment 24 participants
Start Date 2024-07-25
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-16